MGROF (MustGrow Biologics) 3-Year EBITDA Growth Rate: -4.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MGROF MustGrow Biologics Corp MGROF
24 GF Score
Price $0.23
! 3 Warning Signs
View Full Analysis

What is MustGrow Biologics 3-Year EBITDA Growth Rate?

MustGrow Biologics MGROF +0.85% 24 3-Year EBITDA Growth Rate is -4.00% as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 229 Agriculture companies, MustGrow Biologics ranks worse than 54.59% on this metric.

MustGrow Biologics's EBITDA per Share for the three months ended in Mar. 2026 was $-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was -4.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of MustGrow Biologics was 43.10% per year. The lowest was -287.10% per year. And the median was -11.20% per year.


MustGrow Biologics  (OTCPK:MGROF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


MustGrow Biologics 3-Year EBITDA Growth Rate Related Terms


MGROF vs CTVA, CF, MOS: 3-Year EBITDA Growth Rate Comparison

For the Agricultural Inputs subindustry, MustGrow Biologics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MustGrow Biologics 3-Year EBITDA Growth Rate vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, MustGrow Biologics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MustGrow Biologics's 3-Year EBITDA Growth Rate falls into.


MGROF
24GF Score
MustGrow Biologics Corp MGROF
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MustGrow Biologics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of -4.00% mean?
MustGrow Biologics (MGROF) has a 3-Year EBITDA Growth Rate of -4.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for MustGrow Biologics and its competitors. According to the industry distribution chart, MustGrow Biologics ranks #125 out of 229 companies in the Agriculture industry, placing it in the top 54.6%.
Is MustGrow Biologics' 3-Year EBITDA Growth Rate too high?
MustGrow Biologics' current 3-Year EBITDA Growth Rate is -4.00%. Based on the distribution chart, MustGrow Biologics ranks #125 out of 229 companies in the Agriculture industry, which is below the industry midpoint. Overall, MustGrow Biologics has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' 3-Year EBITDA Growth Rate compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #125 out of 229 companies for 3-Year EBITDA Growth Rate. This places MustGrow Biologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Agriculture company?
A good 3-Year EBITDA Growth Rate depends on the Agriculture industry context. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for MustGrow Biologics and its competitors. MustGrow Biologics's current 3-Year EBITDA Growth Rate is -4.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current 3-Year EBITDA Growth Rate of -4.00%. The current 3-Year EBITDA Growth Rate is -4.00%. MustGrow Biologics' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current 3-Year EBITDA Growth Rate is -4.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MustGrow Biologics Business Description

Other Exchanges 0C0:GermanyMGRO:Canada
Address 1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
24GF Score

Get the complete analysis for MGROF

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.23
Price